Androgen deficit changes the response to antidepressant drugs in tail suspension test in mice

References

• Fink JE, Hackney AC, Matsumoto M, et al. Mobility and biomechanical functions in the aging male: testosterone and the locomotive syndrome. Aging Male. [cited 2018 Sep 29]; [8 p.]. DOI:10.1080/13685538.2018.1504914
   Google Scholar
• Gagliano-Jucá T, Basaria S, Gagliano-Jucá T, et al. Testosterone replacement therapy and cardiovascular risk. Nat Rev Cardiol. 2019;16(9):555–574.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li J, Cheng X, et al. testosterone level in aging male with different glucose tolerance state and its association with osteocalcin. Nat Rev Cardiol. 2019;22(1):68–73.
   Google Scholar
• Kwon H, Lee D-G, Kang HC, et al. The relationship between testosterone, metabolic syndrome, and mean carotid intima-media thickness in aging men. Aging Male. 2014;17(4):211–215.
   PubMed Web of Science ®Google Scholar
• Peña CJ, Nestler EJ. Progress in epigenetics of depression. Prog Mol Biol Transl Sci. 2018;157:41–66.
   PubMed Web of Science ®Google Scholar
• Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74(1):67–83.
   PubMed Web of Science ®Google Scholar
• Khosravi S, Ardebili HE, Larijani B. Are andropause symptoms related to depression?. Aging Clin Exp Res. 2015;27(6):813–820.
   PubMed Web of Science ®Google Scholar
• Birkhäuser M. Depression, menopause and estrogens: is there a correlation?. Maturitas. 2002;41(Suppl 1):S3–S8.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Zilio M, Shuwisitkul D. Modified biomolecule as potential vehicle for buccal delivery of doxepin. Ther Deliv. 2016;7(10):683–689.
   PubMed Web of Science ®Google Scholar
• Manao K, Yuri H, Kayoko F, et al. Anti-depressant fluoxetine reveals its therapeutic effect via astrocytes. EBioMedicine. 2018;32:72–83.
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Rakhshan R, Ghaderi H. Comparison of effect of Lavandula officinalis and venlafaxine in treating depression: a double blind clinical trial. J Clin Diagn Res. 2017;11(7):KC01–KC04.
   PubMed Web of Science ®Google Scholar
• Hernandez-Hernandez OT, Martinez-Mota L, Herrera-Perez JJ, et al. Role of estradiol in the expression of genes involved in serotonin neurotransmission: implications for female depression. Curr Neuropharmacol. 2019;17(5):459–471.
   PubMed Web of Science ®Google Scholar
• Pae CU, Mandelli L, Kim TS, et al. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother. 2009;63(3):228–235.
   PubMed Web of Science ®Google Scholar
• Felix-Patrício B, Miranda AF, Medeiros JL, et al. The prostate after castration and hormone replacement in a rat model: structural and ultrastructural analysis. Int Braz J Urol. 2017;43(5):957–965.
   PubMed Web of Science ®Google Scholar
• Steru L, Chermat R, Thierry B, et al. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985;85(3):367–370.
   PubMed Web of Science ®Google Scholar
• Can A, Dao DT, Terrillion CE, et al. The tail suspension test. J Vis Exp. 2012;59:e3769.
   Google Scholar
• Ajo R, Segura A, Mira L, et al. The relationship of salivary testosterone and male sexual dysfunction in opioid-associated androgen deficiency (OPIAD). Aging Male. 2017;20(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kaya E, Sikka SC, Kadowitz PJ, et al. Aging and sexual health: getting to the problem. Aging Male. 2017;20(2):65–80.
   PubMed Web of Science ®Google Scholar
• Carruthers M, Cathcart P, Feneley MR. Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes. Aging Male. 2015;18(4):217–227.
   PubMed Web of Science ®Google Scholar
• Nucci RAB, Teodoro ACS, Krause Neto W, et al. Effects of testosterone administration on liver structure and function in aging rats. Aging Male. 2017;20(2):134–137.
   PubMed Web of Science ®Google Scholar
• Kummer KK, Pope HG, Hudson JI, et al. Aging male symptomatology and eating behavior. Aging Male. 2019;22(1):55–61.
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Kawa G, Kinoshita H, et al. Symptomatic change in Japanese hypogonadal patients several years after androgen replacement therapy. Aging Male. 2011;14(3):190–194.
   PubMed Web of Science ®Google Scholar
• Horie S, Hisasue S-i, Nakao M, et al. Correlation between the Japanese Aging Male Questionnaire (JAMQ) and Aging Male’s Symptom (AMS) scale in Japanese male. Aging Male. 2014;17(1):35–41.
   PubMed Web of Science ®Google Scholar
• Erenpreiss J, Fodina V, Pozarska R, et al. Prevalence of testosterone deficiency among aging men with and without morbidities. Aging Male. [cited 2019 Jun 1]; [5p.].DOI:10.1080/13685538.2019.1621832
   PubMed Web of Science ®Google Scholar
• Groti K, Žuran I, Antonič B, et al. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. Aging Male. 2018;21(3):158–169.
   PubMed Web of Science ®Google Scholar
• Miller KK, Wexler TL, Zha AM, et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry. 2007;68(6):959–965.
   PubMed Web of Science ®Google Scholar
• Mohamad NV, Wong SK, Wan Hasan WN, et al. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019;22(2):129–140.
   PubMed Web of Science ®Google Scholar
• Thase M, Asami Y, Wajsbrot D, et al. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder. Curr Med Res Opin. 2017;33(2):317–326.
   PubMed Web of Science ®Google Scholar
• Naito S, Sato K, Yoshida K, et al. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients. Psychiatry Clin Neurosci. 2007;61(4):421–427.
   PubMed Web of Science ®Google Scholar
• Gur E, Dremencov E, Van De Kar LD, et al. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. Eur J Pharmacol. 2002;436(1-2):57–65.
   PubMed Web of Science ®Google Scholar
• Voigt JP, Fink H. Serotonin controlling feeding and satiety. Behav Brain Res. 2015;277:14–31.
   PubMed Web of Science ®Google Scholar
• Boutrel B, Franc B, Hen R, et al. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J Neurosci. 1999;19(8):3204–3212.
   PubMed Web of Science ®Google Scholar
• Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med. 2000;32(3):210–221.
   PubMed Web of Science ®Google Scholar
• Giuliano F. 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends Neurosci. 2007;30(2):79–84.
   PubMed Web of Science ®Google Scholar
• Tiger M, Varnäs K, Okubo Y, et al. The 5-HT(1B) receptor – a potential target for antidepressant treatment. Psychopharmacology (Berl). 2018;235(5):1317–1334.
   PubMed Web of Science ®Google Scholar
• Carlini EA, Noto AR, Nappo SA, et al. Fluoxetina: indícios de uso inadequado. Jornal Brasileiro de Psiquiatria. 2009;58(2):97–100.
   Google Scholar
• Hodes GE, Hill-Smith TE, Lucki I. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci Lett. 2010;484(1):12–16.
   PubMed Web of Science ®Google Scholar
• Spritzer MD, Roy EA. Testosterone and adult neurogenesis. Biomolecules. 2020;10(2):225.
   Web of Science ®Google Scholar
• Wilson K, Mottram P. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry. 2004;19(8):754–762.
   PubMed Web of Science ®Google Scholar